Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway
2019 · Autophagy · 182 citations
https://doi.org/10.1080/15548627.2019.1687213
M
Martin Nurmik
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
1.2K
Citations
7
h-index
7
i10-index
Martin Nurmik is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Cancer Cells and Metastasis & 3D Printing in Biomedical Research & Cancer, Hypoxia, and Metabolism. The author has an h-index of 7, co-authored 12 publications.
ORCID: 0000-0002-6350-0577Papers by this author
worksAssessing personalized responses to anti-PD-1 treatment using patient-derived lung tumor-on-chip
2024 · Cell Reports Medicine · 30 citations
https://doi.org/10.1016/j.xcrm.2024.101549
Protocol for the biofabrication of immunocompetent tumor-on-chip models from patient solid tumors for assessment of anticancer therapies
2025 · STAR Protocols · 3 citations
https://doi.org/10.1016/j.xpro.2025.103895
Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.11292644
Abstract PS4-04-06: Tumor-on-chip as a personalized platform for rapid drug testing in breast cancer
2026 · Clinical Cancer Research · 0 citations
https://doi.org/10.1158/1557-3265.sabcs25-ps4-04-06
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat